PTPRQ
protein-codingprotein tyrosine phosphatase receptor type Q, the group of Fibronectin type III domain containing|Protein tyrosine phosphatases receptor type
Gene summary
This locus encodes a member of the type III receptor-like protein-tyrosine phosphatase family. The encoded protein catalyzes the dephosphorylation of phosphotyrosine and phosphatidylinositol and plays roles in cellular proliferation and differentiation. Mutations at this locus have been linked to autosomal recessive deafness. [provided by RefSeq, Mar 2014]
- DFNB84
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~278.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013249
Submitter: PanelApp Australia
Inheritance Pattern: SD
Disease ID:MONDO:0013249
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013249
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0019588
Submitter: Orphanet
Inheritance Pattern: Unknown
Disease ID:MONDO:0033260
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013249
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0033260
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013249
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0019587
Submitter: Orphanet
Inheritance Pattern: Unknown
Disease ID:MONDO:0019588
Submitter: ClinGen
Inheritance Pattern: AD
Disease ID:MONDO:0033260
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
Comments: In Deafness, autosomal dominant 73, the onset of hearing loss has been described as variable but typically postlingual
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PTPRQ variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001145026.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 16 | 47 | 4 | 68 | |
| missense | 1 | 1 | 279 | 37 | 13 | 331 |
| nonsense | 9 | 21 | 1 | 31 | ||
| start loss | 2 | 2 | ||||
| frameshift | 10 | 23 | 1 | 34 | ||
| splice donor/acceptor (+/-2bp) | 5 | 12 | 5 | 22 | ||
| Total | 26 | 59 | 301 | 84 | 18 | 488 |
Highest pathogenic variant AF is 0.00008587116
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001138498.1 | 45 | MANE Select | |
| Ensembl | ENSP00000495607.1 | 45 | MANE Select | |
| Ensembl | ENSP00000448844.1 | 8 | Standard | |
| Ensembl | ENSP00000449526.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- peptidyl-tyrosine dephosphorylation
- regulation of fat cell differentiation
Molecular Function
- protein tyrosine phosphatase activity
Cellular Component
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000266688
- Coding exons
- 50
- Length
- 273029
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.999 | 838 | 923 | 0.908 | 0.0000450 | 14874 |
| Missense (PolyPhen) | 285 | 337.62 | 0.84414 | 5371 | ||
| Synonymous | 0.177 | 324 | 328 | 0.988 | 0.0000174 | 4365 |
| Loss of Function | 3.93 | 48 | 87.8 | 0.547 | 0.00000440 | 1494 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Phosphatidylinositol phosphatase required for auditory function. May act by regulating the level of phosphatidylinositol 4,5-bisphosphate (PIP2) level in the basal region of hair bundles. Can dephosphorylate a broad range of phosphatidylinositol phosphates, including phosphatidylinositol 3,4,5-trisphosphate and most phosphatidylinositol monophosphates and diphosphates. Phosphate can be hydrolyzed from the D3 and D5 positions in the inositol ring. Has low tyrosine-protein phosphatase activity; however, the relevance of such activity in vivo is unclear. Plays an important role in adipogenesis of mesenchymal stem cells (MSCs). Regulates the phosphorylation state of AKT1 by suppressing the phosphatidylinositol 3,4,5-trisphosphate (PIP3) level in MSCs and preadipocyte cells. {ECO:0000269|PubMed:19351528}.;
- Disease
- DISEASE: Deafness, autosomal recessive, 84A (DFNB84A) [MIM:613391]: A form of non-syndromic deafness characterized by progressive, sensorineural hearing loss and vestibular dysfunction. {ECO:0000269|PubMed:20346435, ECO:0000269|PubMed:20472657}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal dominant, 73 (DFNA73) [MIM:617663]: A form of non-syndromic hearing loss characterized by mild to severe bilateral symptoms with variable age of onset from early childhood to the third decade. {ECO:0000269|PubMed:29309402}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.105
Essentials
- Essential (CRISPR2)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.135
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |